在报告了畜牧疾病治疗前临床结果后,Genflow Biosciences的股份上. Genflow Biosciences shares rose after positive preclinical results in livestock disease treatments were reported.

中转生物科学PLC报告了其动物健康方案的进展,重点介绍了在开发牲畜疾病治疗方法方面取得的进展。 Genflow Biosciences PLC reported progress on its animal health program, highlighting advancements in developing treatments for livestock diseases. 该公司强调,尽管没有披露具体的时间表或产品名称,但临床前期结果和正在进行的监管讨论是积极的。 The company emphasized positive preclinical results and ongoing regulatory discussions, though no specific timelines or product names were disclosed. 最新情况反映了对农业生物技术的持续投资,旨在改善动物福利和农业生产力。 The update reflects continued investment in agricultural biotechnology aimed at improving animal welfare and farm productivity.